Apostolopoulos V - Search Results

1

Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide.

Lazoura E, Lodding J, Farrugia W, Ramsland PA, Stevens J, Wilson IA, Pietersz GA, Apostolopoulos V. Lazoura E, et al. Among authors: apostolopoulos v. Immunology. 2006 Nov;119(3):306-16. doi: 10.1111/j.1365-2567.2006.02434.x. Immunology. 2006. PMID: 17067310 Free PMC article.

2

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IF. Apostolopoulos V, et al. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10128-32. doi: 10.1073/pnas.92.22.10128. Proc Natl Acad Sci U S A. 1995. PMID: 7479739 Free PMC article.

3

Peptide binding sites recognized by anti-mucin (MUC2) monoclonal antibodies.

Xing PX, Apostolopoulos V, Prenzoska J, Devine PL, McKenzie IF. Xing PX, et al. Among authors: apostolopoulos v. Scand J Immunol. 1993 Dec;38(6):591-2. doi: 10.1111/j.1365-3083.1993.tb03246.x. Scand J Immunol. 1993. PMID: 7504828

4

Cellular mucins: targets for immunotherapy.

Apostolopoulos V, McKenzie IF. Apostolopoulos V, et al. Crit Rev Immunol. 1994;14(3-4):293-309. doi: 10.1615/critrevimmunol.v14.i3-4.40. Crit Rev Immunol. 1994. PMID: 7538768 Review.

5

CTL in mice immunized with human mucin 1 are MHC-restricted.

Apostolopoulos V, Loveland BE, Pietersz GA, McKenzie IF. Apostolopoulos V, et al. J Immunol. 1995 Dec 1;155(11):5089-94. J Immunol. 1995. PMID: 7594517

6

The immunogenicity of MUC1 peptides and fusion protein.

Apostolopoulos V, Pietersz GA, Xing PX, Lees CJ, Michael M, Bishop J, McKenzie IF. Apostolopoulos V, et al. Cancer Lett. 1995 Mar 23;90(1):21-6. doi: 10.1016/0304-3835(94)03673-7. Cancer Lett. 1995. PMID: 7720038 Clinical Trial.

7

Cell-mediated immune responses to MUC1 fusion protein coupled to mannan.

Apostolopoulos V, Pietersz GA, McKenzie IF. Apostolopoulos V, et al. Vaccine. 1996 Jun;14(9):930-8. doi: 10.1016/0264-410x(95)00258-3. Vaccine. 1996. PMID: 8843637

8

Breast cancer immunotherapy: current status and future prospects.

Apostolopoulos V, McKenzie IF, Pietersz GA. Apostolopoulos V, et al. Immunol Cell Biol. 1996 Oct;74(5):457-64. doi: 10.1038/icb.1996.76. Immunol Cell Biol. 1996. PMID: 8912009 Review.

9

Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen.

Lofthouse SA, Apostolopoulos V, Pietersz GA, Li W, McKenzie IF. Lofthouse SA, et al. Among authors: apostolopoulos v. Vaccine. 1997 Oct;15(14):1586-93. doi: 10.1016/s0264-410x(97)00077-7. Vaccine. 1997. PMID: 9330472

10

MUC1 peptide epitopes associated with five different H-2 class I molecules.

Apostolopoulos V, Haurum JS, McKenzie IF. Apostolopoulos V, et al. Eur J Immunol. 1997 Oct;27(10):2579-87. doi: 10.1002/eji.1830271017. Eur J Immunol. 1997. PMID: 9368613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters